Reprinted with the kind permission of Celeste Cooper
According to a spokesperson, the genetic studies on fibromyalgia are well underway – with the assistance of the University of California, UCLA, and University of Illinois at Chicago. There has been a strong response from the fibromyalgia community in participating in these efforts.
As you may recall from my blog, The FM/a® Blood Test and Campaign 250: Participation in Fibromyalgia Exome and Treatment Study, EpicGenetics is allowing up to 250,000 participants in this research effort and the opportunity to enroll will likely end later in 2018 to allow for the analysis of the genomic surveys and results announcement.
So, if you haven’t already, I encourage you to look into getting the FM/a test now, so you can be part of this important research. Participation in the research first requires a positive FM/a® Test, and if you do receive a positive test result, you will receive a direct communication from EpicGenetics inviting you to participate.
Additionally, the clinical trial set to take place at Massachusetts General Hospital to evaluate the BCG vaccine as a direct, effective treatment continues to progress toward enrollment and trial initiation. Plans are to initiate the trials during the first half of this year.
You can read more about this breaking news in my blog, EpicGenetics Announces Major Clinical Study to Locate Genetic Markers Unique to People with Fibromyalgia and Explore New Treatment Approaches.
Thank you for taking this journey with me.